Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

Clinical Outcomes From NOCD Digital Behavioral Health Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04701372

Enrollment

2069

Registered

2021-01-08

Start date

2020-01-01

Completion date

2020-11-08

Last updated

2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

exposure and response prevention, digital behavioral health, remote treatment, video therapy

Brief summary

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Interventions

BEHAVIORALExposure and response prevention therapy

Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to No maximum

Healthy volunteers

Inclusion criteria

* obsessive-compulsive disorder

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Dimensional Obsessive-Compulsive Scale	change from pre-treatment to post-treatment (after 11 weeks)	self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes

Secondary

Measure	Time frame	Description
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	clinician-rated psychometric instrument to measure overall OCD symptom severity
Depression Anxiety and Stress Scale (DASS-21)	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	self-rated psychometric instrument to measure depression, anxiety, and stress
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)	pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)	self-rated psychometric instrument to measure quality of life

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026